Details for New Drug Application (NDA): 020298
✉ Email this page to a colleague
The generic ingredient in ALOPRIM is allopurinol sodium. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.
Summary for 020298
Tradename: | ALOPRIM |
Applicant: | Mylan |
Ingredient: | allopurinol sodium |
Patents: | 0 |
Pharmacology for NDA: 020298
Mechanism of Action | Xanthine Oxidase Inhibitors |
Suppliers and Packaging for NDA: 020298
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALOPRIM | allopurinol sodium | INJECTABLE;INJECTION | 020298 | NDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1323 | 51662-1323-1 | 1 KIT in 1 KIT (51662-1323-1) * 1 mL in 1 VIAL * 1 mL in 1 SYRINGE |
ALOPRIM | allopurinol sodium | INJECTABLE;INJECTION | 020298 | NDA | Mylan Institutional LLC | 67457-187 | 67457-187-50 | 1 VIAL, GLASS in 1 CARTON (67457-187-50) / 25 mL in 1 VIAL, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | May 17, 1996 | TE: | AP | RLD: | Yes |
Complete Access Available with Subscription